Synthesis of 1,2-Dihydrofuro[3,4-d]pyrimidine Derivatives as Potential VEGFR-2 Inhibitors, and Proposed Mechanism for the 5,6-Dihydro-4H-furo[3,4-c]pyrrol-4-one
dc.authorid | Suekinci Yilmaz, Aysen/0000-0002-1928-0204 | |
dc.contributor.author | Yilmaz, Aysen Suekinci | |
dc.contributor.author | Kacan, Mesut | |
dc.date.accessioned | 2024-06-12T10:59:00Z | |
dc.date.available | 2024-06-12T10:59:00Z | |
dc.date.issued | 2023 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | The fourteen novel 1,2-dihydrofuro[3,4-d]pyrimidine compounds were synthesized from 4-(2-azido-2-oxoethyl)furan-3-carbonyl azide, by the two selected Curtius rearrangement, nucleophilic addition, and intramolecular cyclization reactions. Molecular docking studies of these compounds were performed with vascular endothelial growth factors receptor-2 (VEGFR-2) tyrosine kinase (PDB ID:3WZE). Cytotoxicity studies against human prostate cancer cells (DU145), revealed that compound 8 e has cytotoxic potential. Additionally, in-silico ADME studies appeared that most of the synthesized compounds obeyed Lipinski's rule. Also, the mechanism for 5,6-dihydro-4H-furo[3,4-c]pyrrol-4-one, which occurs in the reaction of isocyanate 2 with thiols, was proposed. The azide group acts as the leaving group in this reaction. | en_US |
dc.description.sponsorship | Trakya University Scientific Research Projects Coordination Unit [TUBAP 2018/199] | en_US |
dc.description.sponsorship | The authors indebted to Trakya University Scientific Research Projects Coordination Unit (TUBAP 2018/199) for financial support for this work. We thank Trakya University Technology Research Development Application and Research Center (TUTAGEM) for the cytotoxicity, Q-TOF and FTIR analyses. | en_US |
dc.identifier.doi | 10.1002/slct.202300150 | |
dc.identifier.issn | 2365-6549 | |
dc.identifier.issue | 17 | en_US |
dc.identifier.scopus | 2-s2.0-85159802011 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.1002/slct.202300150 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/20280 | |
dc.identifier.volume | 8 | en_US |
dc.identifier.wos | WOS:000980143700001 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley-V C H Verlag Gmbh | en_US |
dc.relation.ispartof | Chemistryselect | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Curtius Rearrengement | en_US |
dc.subject | Intramolecular Cyclization | en_US |
dc.subject | Lipinski Rule | en_US |
dc.subject | Azide Elimination | en_US |
dc.subject | Protein-Ligand Interaction | en_US |
dc.subject | Endothelial Growth-Factor | en_US |
dc.subject | Cancer Cells | en_US |
dc.subject | Acyl Azide | en_US |
dc.subject | Design | en_US |
dc.subject | Kinase | en_US |
dc.subject | Progression | en_US |
dc.subject | Expression | en_US |
dc.subject | Receptors | en_US |
dc.title | Synthesis of 1,2-Dihydrofuro[3,4-d]pyrimidine Derivatives as Potential VEGFR-2 Inhibitors, and Proposed Mechanism for the 5,6-Dihydro-4H-furo[3,4-c]pyrrol-4-one | en_US |
dc.type | Article | en_US |